These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7892452)

  • 1. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging.
    Martín J; Sentís M; Zidan A; Donoso L; Puig J; Falcó J; Bella R
    Radiology; 1995 Apr; 195(1):125-30. PubMed ID: 7892452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
    Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
    Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience.
    Qayyum A; Goh JS; Kakar S; Yeh BM; Merriman RB; Coakley FV
    Radiology; 2005 Nov; 237(2):507-11. PubMed ID: 16244259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma.
    Krinsky GA; Lee VS; Nguyen MT; Rofsky NM; Theise ND; Morgan GR; Teperman LW; Weinreb JC
    Radiology; 2001 Jan; 218(1):47-53. PubMed ID: 11152778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation.
    Krinsky GA; Lee VS; Theise ND; Weinreb JC; Rofsky NM; Diflo T; Teperman LW
    Radiology; 2001 May; 219(2):445-54. PubMed ID: 11323471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging.
    Ito K; Mitchell DG; Gabata T; Hann HW; Kim PN; Fujita T; Awaya H; Honjo K; Matsunaga N
    Radiology; 1999 Jul; 212(1):235-40. PubMed ID: 10405747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings.
    Kanematsu M; Osada S; Amaoka N; Goshima S; Kondo H; Kato H; Nishibori H; Yokoyama R; Hoshi H; Moriyama N
    AJR Am J Roentgenol; 2005 Mar; 184(3):832-41. PubMed ID: 15728605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation.
    Rosenkrantz AB; Campbell N; Wehrli N; Triolo MJ; Kim S
    Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
    Yoshioka H; Sato J; Takahashi N; Lou D; Yamaguchi M; Saida Y; Itai Y
    Magn Reson Imaging; 2004 Apr; 22(3):361-7. PubMed ID: 15062931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in-phase and opposed-phase GRE and conventional SE MR pulse sequences in T1-weighted imaging of liver lesions.
    Martín J; Sentis M; Puig J; Rué M; Falcó J; Donoso L; Zidan A
    J Comput Assist Tomogr; 1996; 20(6):890-7. PubMed ID: 8933787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerating nodules of liver cirrhosis: MR imaging.
    Itai Y; Ohnishi S; Ohtomo K; Kokubo T; Yoshida H; Yoshikawa K; Imawari M
    Radiology; 1987 Nov; 165(2):419-23. PubMed ID: 2821574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.
    Bhartia B; Ward J; Guthrie JA; Robinson PJ
    AJR Am J Roentgenol; 2003 Mar; 180(3):577-84. PubMed ID: 12591657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.